Covid-19 roundup: As­traZeneca re­sumes vac­cine tri­als in Japan; Glob­al lab net­work is es­tab­lished to com­pare Covid-19 vac­cines

As­traZeneca has re­sumed tri­als of its Ox­ford Uni­ver­si­ty-de­vel­oped Covid-19 vac­cine in Japan, while US test­ing re­mains on hold.

The tri­als screeched to a halt ear­li­er this month, af­ter a British par­tic­i­pant de­vel­oped what’s be­lieved to be trans­verse myelitis, a spinal in­flam­ma­to­ry dis­or­der.

While the UK, Brazil, In­dia and South Africa have al­lowed test­ing to con­tin­ue, the US is tak­ing a deep­er look in­to the po­ten­tial­ly se­vere ad­verse event. The FDA has re­quest­ed to see tri­al da­ta for sim­i­lar vac­cines de­vel­oped by Ox­ford Uni­ver­si­ty re­searchers, un­named sources told Reuters.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER